These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21791828)
21. Mucopolysaccharidoses: early diagnostic signs in infants and children. Galimberti C; Madeo A; Di Rocco M; Fiumara A Ital J Pediatr; 2018 Nov; 44(Suppl 2):133. PubMed ID: 30442162 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of 2 children with mucopolysaccharidosis by allogeneic hematopoietic stem cell transplantation]. Chen J; Jiang H; Dong L; Wang Y; Luo C; Zhou M; Zhang W; Huang S; Gu X; Qiu W; Zhang H; Gu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):675-7. PubMed ID: 19065530 [TBL] [Abstract][Full Text] [Related]
23. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015 [TBL] [Abstract][Full Text] [Related]
25. Unique medical issues in adult patients with mucopolysaccharidoses. Mitchell J; Berger KI; Borgo A; Braunlin EA; Burton BK; Ghotme KA; Kircher SG; Molter D; Orchard PJ; Palmer J; Pastores GM; Rapoport DM; Wang RY; White K Eur J Intern Med; 2016 Oct; 34():2-10. PubMed ID: 27296591 [TBL] [Abstract][Full Text] [Related]
26. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ; Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196 [TBL] [Abstract][Full Text] [Related]
27. [Principles of therapeutic approaches for mucopolysaccharidoses]. Caillaud C Arch Pediatr; 2014 Jun; 21 Suppl 1():S39-45. PubMed ID: 25063383 [TBL] [Abstract][Full Text] [Related]
28. Radiologic and neuroradiologic findings in the mucopolysaccharidoses. Lachman R; Martin KW; Castro S; Basto MA; Adams A; Teles EL J Pediatr Rehabil Med; 2010; 3(2):109-18. PubMed ID: 21791838 [TBL] [Abstract][Full Text] [Related]
30. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748 [TBL] [Abstract][Full Text] [Related]
31. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future. Taylor M; Khan S; Stapleton M; Wang J; Chen J; Wynn R; Yabe H; Chinen Y; Boelens JJ; Mason RW; Kubaski F; Horovitz DDG; Barth AL; Serafini M; Bernardo ME; Kobayashi H; Orii KE; Suzuki Y; Orii T; Tomatsu S Biol Blood Marrow Transplant; 2019 Jul; 25(7):e226-e246. PubMed ID: 30772512 [TBL] [Abstract][Full Text] [Related]
32. Current and new therapies for mucopolysaccharidoses. Penon-Portmann M; Blair DR; Harmatz P Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S10-S17. PubMed ID: 36464587 [TBL] [Abstract][Full Text] [Related]
33. Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms. Shapiro EG; Jones SA; Escolar ML Mol Genet Metab; 2017 Dec; 122S():1-7. PubMed ID: 29074036 [TBL] [Abstract][Full Text] [Related]
34. Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions. Wolfberg J; Chintalapati K; Tomatsu S; Nagao K Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32759694 [TBL] [Abstract][Full Text] [Related]
35. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia. Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975 [TBL] [Abstract][Full Text] [Related]
36. [Chemotactic activity of fibroblasts in mucopolysaccharidoses]. Albini A; Pontz B; Mensing H; Cantz M; Müller PK Padiatr Padol; 1983; 18(3):263-7. PubMed ID: 6412199 [TBL] [Abstract][Full Text] [Related]
37. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses. Peck SH; Casal ML; Malhotra NR; Ficicioglu C; Smith LJ Mol Genet Metab; 2016 Aug; 118(4):232-43. PubMed ID: 27296532 [TBL] [Abstract][Full Text] [Related]
38. Reliable detection of mucopolysacchariduria in dried-urine filter paper samples. Civallero G; Bender F; Gomes A; Marasca G; Guidobono R; De Mari J; Burin M; Giugliani R Clin Chim Acta; 2013 Jan; 415():334-6. PubMed ID: 23178442 [TBL] [Abstract][Full Text] [Related]
39. Pathophysiology, evaluation, and management of sleep disorders in the mucopolysaccharidoses. Rapoport DM; Mitchell JJ Mol Genet Metab; 2017 Dec; 122S():49-54. PubMed ID: 28964643 [TBL] [Abstract][Full Text] [Related]
40. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. McGlynn R; Dobrenis K; Walkley SU J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]